| 物质名称 | CAS登记号 | 物质唯一标识 | 分子式 | 异名/同义词 |
|---|---|---|---|---|
| CETUXIMAB | 205923-56-4 | PQX0D8J21J | CETUXIMAB BIOSIMILAR (SHANGHAI ZHANGJIANG) CMAB-009 CMAB-009 (BIOSIMILAR OF CETUXIMAB) CMAB009 CETUXIMAB BETA CETUXIMAB BETA [INN] ABP-494 CETUXIMAB BIOSIMILAR (ABP-494) C-225 C225 CETUXIMAB (GENETICAL RECOMBINATION) CETUXIMAB (GENETICAL RECOMBINATION) [JAN] CETUXIMAB [EMA EPAR] CETUXIMAB [HSDB] CETUXIMAB [JAN] CETUXIMAB [MART.] CETUXIMAB [MI] CETUXIMAB [PURPLE BOOK CDER] CETUXIMAB [USAN] CETUXIMAB [VANDF] CETUXIMAB CETUXIMAB [WHO-DD] ERBITUX EXTRACELLULAR DOMAIN HUMAN EGFR BINDING RECOMBINANT, HUMAN/MOUSE CHIMERIC MONOCLONAL ANTIBODY FV REGIONS OF MURINE ANTI-EGFR ANTIBODY WITH HUMAN IGG1 HEAVY AND KAPPA LIGHT CHAIN CONSTANT REGIONS, MW 152000 IMC-225 IMC-C225 IMCC-225 IMCC225 IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER MOAB C225 CETUXIMAB [INN] |